Skip to main content
SpringerLink
Log in

Motor Impairment and Disability Scales

  • Chapter
  • First Online:
Guide to Assessment Scales in Parkinson’s Disease

Abstract

An increasing number of scales used to assess Parkinson’s disease (PD) motor manifestations (tremor, rigidity, bradykinesia) and disability have been developed in the past years. However, some of them lack appropriate validation. In this chapter, the most widely used and tested scales to assess motor manifestations and disability are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Marinus J, Visser M, Stiggelbout AM, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson’s disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatr. 2004;75:388-395.

    Google Scholar 

  2. Martinez-Martin P, Benito-Leon J, Burguera JA, et al. The SCOPA-Motor Scale for assessment of Parkinson’s disease is a consistent and valid measure. J Clin Epidemiol. 2005;58:674-679.

    Google Scholar 

  3. Forjaz MJ, Carod FJ, Virues J, et al. The SCOPA motor scale in Latin-America: Metric properties. Mov Disord. 2007;22:S193.

    Google Scholar 

  4. Wilson RE, Seeberger LC, Buck PO, et al. Investigation of the psychometric properties of the short Parkinson’s evaluation scale/scales for outcomes in Parkinson’s disease (SPES/SCOPA). Mov Disord. 2010;25:S348.

    Google Scholar 

  5. Schwab JF England AC. Projection technique for evaluating surgery in Parkinson’s disease. In: Gillingham FJ, Donaldson MC, eds. Third Symposium on Parkinson’s Disease. Edinburgh, Scotland: E & S Livingston. 1969;152-157

    Google Scholar 

  6. McRae C, Diem G, Vo A, et al. Schwab & England: Standardization of administration. Mov Disord. 2000;15:335-336.

    Google Scholar 

  7. Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov Disord. 2002;17:867-876.

    Google Scholar 

  8. Martinez-Martin P, Forjaz MJ. Metric attributes of the unified Parkinson’s disease rating scale 3.0 battery: Part I, feasibility, scaling assumptions, reliability, and precision. Mov Disord. 2006;21:1182-1188.

    Google Scholar 

  9. Martinez-Martin P, Prieto L, Forjaz MJ. Longitudinal metric properties of disability rating scales for Parkinson’s disease. Value Health. 2006;9:386-393.

    Google Scholar 

  10. Forjaz MJ, Martinez-Martin P. Metric attributes of the unified Parkinson’s disease rating scale 3.0 battery: part II, construct and content validity. Mov Disord. 2006;21:1892-1898.

    Google Scholar 

  11. Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson’s Disease Rating Scale: Motor Examination section. Mov Disord. 1998;13:633-636.

    Google Scholar 

  12. Martinez-Martin P, Gil-Nagel A, Morlan Gracia L, et al. Intermediate scale for assessment of Parkinson’s disease. Characteristics and structure. Parkinsonism Relat Disord. 1995;1:97-102.

    Google Scholar 

  13. Martinez-Martin P, Garcia Urra D, del Ser Quijano T, et al. A new clinical tool for gait evaluation in Parkinson’s disease. Clin Neuropharmacol. 1997;20:183-194.

    Google Scholar 

  14. Martinez-Martin P, Cubo E. Scales to measure parkinsonism. In: Koller W, Melamed E, eds. Handbook of Clinical Neurology: Parkinson’s Disease and Related Disorders, Part I. Edinburgh:Elsevier; 2007:291-327.

    Google Scholar 

  15. Molina J, Gonzalez de la Aleja J, Bermejo-Pareja F, Martinez-Martin P. Trastornos del movimiento. I. Enfermedad de Parkinson y parkinsonismos. In: Bermejo-Pareja F, Porta-Etessam J, Diaz-Guzman J, Martinez-Martin P, eds. Más de cien escalas en Neurología. Madrid: Aula Medica; 2008:183-224.

    Google Scholar 

  16. Serrano-Duenas M, Calero B, Serrano S, et al. Psychometric attributes of the rating scale for gait evaluation in Parkinson’s disease. Mov Disord. 2010;25:2121-2127.

    Google Scholar 

  17. O’Sullivan JD, Said CM, Dillon LC, et al. Gait analysis in patients with Parkinson’s disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function. Mov Disord. 1998;13:900-906.

    Google Scholar 

  18. Guy W. Abnormal Involuntary Movement Scale. ECDEU Assessment manual for psychopharmacology. Revised. Rockville, MD: National Institure of Mental Health, US Department of Health, Education and Welfare; 1976.

    Google Scholar 

  19. Colosimo C, Martinez-Martin P, Fabbrini G, et al. Task force report on scales to assess dyskinesia in Parkinson’s disease: critique and recommendations. Mov Disord. 2010;25:1131-1142.

    Google Scholar 

  20. Whall AL, Engle V, Edwards A, et al. Development of a screening program for tardive dyskinesia: feasibility issues. Nurs Res. 1983;32:151-156.

    Google Scholar 

  21. Sweet RA, DeSensi EG, Zubenko GS. Reliability and applicability of movement disorder rating scales in the elderly. J Neuropsychiatry Clin Neurosci. 1993;5:56-60.

    Google Scholar 

  22. Katzenschlager R, Schrag A, Evans A, et al. Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure. Neurology. 2007;69:555-563.

    Google Scholar 

  23. Hoff JI, Van den Plas AA, Wagemans EA, Van Hilten JJ. Accelerometric assessment of levodopa-induced dyskinesias in Parkinson’s disease. Mov Disord. 2001;16:58-61.

    Google Scholar 

  24. Chapuis S, Ouchchane L, Metz O, et al. Impact of the motor complications of Parkinson’s disease on the quality of life. Mov Disord. 2005;20:224-230.

    Google Scholar 

  25. Goetz CG, Damier P, Hicking C, et al. Sarizotan as a treatment for dyskinesias in Parkinson’s disease: a double-blind placebo-controlled trial. Mov Disord. 2007;22:179-186.

    Google Scholar 

  26. Martinez-Martin P, Valldeoriola F, Tolosa E, et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson’s disease. Mov Disord. 2002;17:372-377.

    Google Scholar 

  27. Goetz CG, Stebbins GT, Shale HM, et al. Utility of an objective dyskinesia rating scale for Parkinson’s disease: inter- and intrarater reliability assessment. Mov Disord. 1994;9:390-394.

    Google Scholar 

  28. Sawada H, Oeda T, Kuno S, et al. Amantadine for dyskinesias in Parkinson’s disease: a randomized controlled trial. PLoS ONE. 2010;5:e15298.

    Google Scholar 

  29. Obeso JA, Grandas F, Vaamonde J, et al. Motor complications associated with chronic levodopa therapy in Parkinson’s disease. Neurology. 1989;39(suppl 2):11-19.

    Google Scholar 

  30. Stacy M, Bowron A, Guttman M, et al. Identification of motor and nonmotor wearing-off in Parkinson’s disease: Comparison of a patient questionnaire versus a clinician assessment. Mov Disord. 2005;20:726-733.

    Google Scholar 

  31. Stacy M, Hauser R. Development of a Patient Questionnaire to facilitate recognition of motor and nonmotor wearing-off in Parkinson’s disease. J Neural Transm. 2007;114:211-217.

    Google Scholar 

  32. Stacy MA, Murphy JM, Greeley DR, et al; for the COMPASS-I Study Investigators. The sensitivity and specificity of the 9-item Wearing-off Questionnaire. Parkinsonism Relat Disord. 2008;14:205-212.

    Google Scholar 

  33. Martinez-Martin P, Hernandez B. The Q10 questionnaire for detection of wearing-off phenomena in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:382-385.

    Google Scholar 

  34. Santens P, De Noordhout AM. Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson’s disease using a dedicated questionnaire: a Belgian multicenter survey. Acta Neurol Belg. 2006;106:137-141.

    Google Scholar 

  35. Martinez-Martin P, Tolosa E, Hernandez B, Badia X. The Patient Card questionnaire to identify wearing-off in Parkinson disease. Clin Neuropharmacol. 2007;30:266-275.

    Google Scholar 

  36. Abbruzzese G, Antonini A, Barone P, et al. Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson’s disease. Neurol Sci. 2012;33:1319-1327.

    Google Scholar 

  37. Silburn PA, Mellick GD, Vieira BI, Danta G, Boyle RS, Herawati L. Utility of a patient survey in identifying fluctuations in early stage Parkinson’s disease. J Clin Neurosci. 2008;15:1235-1239.

    Google Scholar 

  38. K, et al. Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson’s disease patients with wearing-off: efficacy, safety and feasibility–an open-label, 6-week study. J Neural Transm. 2010;117:333-342.

    Google Scholar 

  39. Litvinenko IV, Odinak MM, Mogil’naia VI, Sologub OS, Sakharovskaia AA. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson’s disease: results of an open-label clinical study]. Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109:51-54.

    Google Scholar 

  40. Stacy MA, Murck H, Kroenke K. Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:57-61.

    Google Scholar 

  41. Martinez-Martin P, Tolosa E, Hernandez B, Badia X; for the ValidQUICK Study Group. Validation of the “QUICK” questionnaire—A tool for diagnosis of “wearing-off” in patients with Parkinson’s disease. Mov Disord. 2008;23:830-836.

    Google Scholar 

  42. Azulay JP, Durif F, Rogez R, Tranchant C, Bourdeix I, Rerat K. [Precoce survey: a new self-assessment patient card for early detection and management of Parkinson disease fluctuations]. Rev Neurol (Paris). 2008;164:354-362.

    Google Scholar 

  43. Chan A, Cheung YF, Yeung MA, et al. A validation study of the Chinese wearing off questionnaire 9-symptom for Parkinson’s disease. Clin Neurol Neurosurg. 2011;113:538-540.

    Google Scholar 

  44. Kondo T, Takahashi K. [Translation and linguistic validation of the Japanese version of the wearing-off questionnaires(WOQ-19 and WOQ-9)]. Brain Nerve. 2011;63:1285-1292.

    Google Scholar 

  45. Bareš M, Rektorova I, Jech R, et al. Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson’s disease? J Neural Transm. 2012;119:373-380.

    Google Scholar 

  46. Stacy M. The wearing-off phenomenon and the use of questionnaires to facilitate its recognition inParkinson’s disease. J Neural Transm. 2010;117:837-846.

    Google Scholar 

  47. Antonini A, Martinez-Martin P, Chaudhuri RK, et al. Wearing-off scales in Parkinson’s disease: Critique and recommendations. Mov Disord. 2011;26:2169-2175.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Center for Epidemiology, ISCIII, Madrid, Madrid, Spain

    Pablo Martinez-Martin

  2. National Centre of Epidemiology Carlos III Institute of Health, Madrid, Spain

    Carmen Rodriguez-Blazquez

  3. Spanish National School of Public Health Carlos III Institute of Health, Madrid, Spain

    Maria João Forjaz

  4. Neurology, Kings College Hospital Denmark Hill, London, UK

    Kallol Ray Chaudhuri

Authors
  1. Pablo Martinez-Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carmen Rodriguez-Blazquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria João Forjaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kallol Ray Chaudhuri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Healthcare

About this chapter

Cite this chapter

Martinez-Martin, P., Rodriguez-Blazquez, C., Forjaz, M.J., Chaudhuri, K.R. (2014). Motor Impairment and Disability Scales. In: Guide to Assessment Scales in Parkinson’s Disease. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-88-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-907673-88-7_4

  • Published:

  • Publisher Name: Springer Healthcare, Tarporley

  • Print ISBN: 978-1-907673-87-0

  • Online ISBN: 978-1-907673-88-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation